Clinical Trials Logo

Clinical Trial Summary

Breast cancer patients who received docetaxel chemotherapy were randomly divided into two groups; experimental group: the patients received intravenous infusion of succinylated gelatin one day before and on the day of chemotherapy, 500ml each time, once per day; control group: observation. Primary endpoint: total incidence of fluid retention. Secondary endpoints: severity and duration of fluid retention, change in quality of life score.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04637308
Study type Interventional
Source Guangdong Provincial People's Hospital
Contact
Status Completed
Phase Phase 2
Start date September 1, 2019
Completion date September 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT05092854 - The Effect of AMP Human Sodium Bicarbonate Lotion on Dehydrated Heat Stress N/A
Completed NCT05111392 - Hydration Dynamics and Influence of Beverage Composition Phase 1/Phase 2
Completed NCT05391607 - Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement Phase 4
Completed NCT03080831 - TOnicity of Perioperative Maintenance SoluTions Phase 4
Completed NCT03848507 - Impact of Hyperoncotic Albumin to Support Blood Loss Replacement Phase 4
Completed NCT04598386 - The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration N/A
Completed NCT05428774 - Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males N/A
Not yet recruiting NCT05786248 - MOdification of Fluid Distribution In 90 Minutes N/A
Recruiting NCT04193995 - Intermittent Fasting as a Means to Lose Fluid Overload and Weight in Complicated Obesity N/A